Efficacy and Safety of a 12-week Treatment with Twice-daily Aclidinium Bromide in COPD Patients (ACCORD COPD I)

By Kerwin Edward M.   D'Urzo Anthony D.   Gelb Arthur F.   Lakkis Hassan   Gil Esther Garcia   Caracta Cynthia F.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 2, 2012-03 ,pp. : 90-101

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel Two Doses Comparative 1-Year Assessment of Safety and Efficacy (COMPASS) Study in Japanese Patients with Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 34, Iss. 3, 2012-09 ,pp. : 229-239

Karger

Access to resources Recommend Favorite

Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD

By Vestbo Jørgen   Vogelmeier Claus   Creemers Jacques   Falques Meritxell   Ribera Anna   Gil Esther Garcia  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 5, 2010-09 ,pp. : 331-336

Informa Healthcare

Access to resources Recommend Favorite

The Safety and Efficacy of Arformoterol and Formoterol in COPD

By Hanania Nicola A.   Donohue James F.   Nelson Harold   Sciarappa Kenneth   Goodwin Elizabeth   Baumgartner R.A.   Hanrahan J. P.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 7, Iss. 1, 2011-02 ,pp. : 17-31

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study

By Beier Jutta  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 4, 2013-08 ,pp. : 511-522

Informa Healthcare

Access to resources Recommend Favorite